This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Blepharitis

Authoring team

Blepharitis is the inflammation of the eyelids (1). It can be acute or chronic but typically the condition is chronic, intermittent (with exacerbations and remissions) and affects both eyes (2).

Chronic blepharitis can be further divided into:

  • staphylococcal (usually ulcerative)
  • seborrhoeic (frequently associated with seborrhoea of the scalp, brows and ears)
  • mixed staphylococcal seborrhoeic
  • meibomian gland dysfunction (MGD) (1,2)

Some clinicians classify according to the anatomic location of the affected part of the eyelid:

  • anterior blepharitis:
    • affects the anterior lid margin and base of the lashes (1)
    • includes staphylococcal, seborrhoeic blepharitis and Demodex folliculorum mite infestation (3)
  • posterior blepharitis:
    • affects the posterior lid margin
    • MGD is a subset because it affects the oil glands in posterior lid
  • marginal blepharitis

Rosacea, seborrhoeic dermatitis, and keratoconjunctivitis sicca are often associated with this condition (3).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.